|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00460 SIHUAN PHARM
Nominal 
0.780 -0.040 (-4.878%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 1,161,218 | 1.310% | 1,146,203 | 949,697 | 1,055,705 | 1,464,197 |
| Cost of Sales | (479,561) | 23.297% | (388,947) | (341,181) | (307,972) | (460,508) |
| Gross Profit | 681,657 | -9.983% | 757,256 | 608,516 | 747,733 | 1,003,689 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | (98,097) | |
| Change in FV & Impairment on Others | (64,231) | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 121,841 | -- | (2,486) | 4,144 | (45,672) | (47,733) | |
| Profit / (Loss) before Taxation | 365,984 | 133.224% | 156,924 | (19,212) | (33,054) | 56,042 | |
| Taxation | (153,405) | 69.079% | (90,730) | (48,746) | (85,886) | (151,943) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 12,125 | -66.698% | 36,409 | 34,534 | 69,296 | 136,277 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 224,704 | 119.003% | 102,603 | (33,424) | (49,644) | 40,376 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 47,271 | -14.636% | 55,376 | 58,621 | 56,094 | 25,259 |
| Depreciation & Amortisation | -- | -- | -- | -- | 122,327 | 179,022 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 2.490 | 124.324% | 1.110 | -0.360 | -0.530 | 0.430 |
| DPS (cts) | 0.000 | -- | 0.990 | 1.900 | 0.000 | 3.300 |
| Dividend Payout Ratio (%) | -- | -- | 89.189% | -- | -- | 767.442% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.674 | -- | 0.477 | 0.474 | 0.472 | 0.778 |
| Remarks: | Real time quote last updated: 28/08/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 224,704 |
| %Change | 119.003% |
| EPS / (LPS) | RMB 0.025 |
| NBV Per Share (¥) | RMB 0.674 |